pharma · CACNA1A Disorders · Niemann-Pick disease type C
IntraBio
Intrabio Ireland Limited
Intrabio Ireland is a pharma organization headquartered in GB. Primary therapeutic focus areas include CACNA1A Disorders, Niemann-Pick disease type C, Ataxia Telangiectasia. NovaPharmaNews links 3 clinical program(s), 0
Austin, USA HQ
44 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Austin, USA
- Employees
- 44
- Programs
- 3
- Drugs
- 3
- Patents
- 0
N-Acetyl-L-Leucine, granules for suspension
Phase 3 · small molecule · CACNA1A Disorders
N-Acetyl-L-Leucine, granules for suspension for CACNA1A Disorders is a Phase 3 program (small_molecule) at Intrabio Ireland Limited with 1 ClinicalTrials.gov record(s).
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Intrabio Ireland Limited
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- CACNA1A Disorders
- Status
- active
- Trials
- 1